NCT03940742View on ClinicalTrials.gov

A Study of Tirzepatide in Participants With Impaired Liver Function

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 22, 2019

Primary Completion Date

September 22, 2020

Study Completion Date

September 22, 2020

Conditions
Hepatic Insufficiency
Interventions
DRUG

Tirzepatide

Administered SC

Trial Locations (3)

32809

Orlando Clinical Research Center, Orlando

70112

New Orleans Center for Clinical Research, New Orleans

92780

Orange County Research Center, Tustin

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03940742 - A Study of Tirzepatide in Participants With Impaired Liver Function | Biotech Hunter | Biotech Hunter